Keyphrases
A1 Receptor
13%
Achalasia
21%
Apoptosis
18%
Arg-Gly-Asp
10%
Breath Test
19%
Celiac Disease
10%
Clinical Presentation
11%
Colon Cancer Cells
13%
Colonoscopy
21%
Concanavalin A (Con A)
25%
Concanavalin A-induced Hepatitis
16%
Crohn's Disease
39%
Diabetic Patients
9%
Dimethyl Sulfoxide
10%
Dimethylthiourea
9%
Endoscopy
10%
Esophagogastroduodenoscopy
12%
Etiology
10%
Fulminant Hepatic Failure
10%
Gastric Cancer
11%
Gastric Epithelial Cells
10%
Gastroenterologist
10%
Glucagon-like
16%
Glucagon-like peptide-1 Receptor (GLP-1R)
17%
Helicobacter Pylori (H. pylori)
100%
Helicobacter Pylori Eradication
12%
Helicobacter Pylori Infection
30%
Hepatic Damage
18%
High-resolution Esophageal Manometry
12%
High-resolution Manometry
17%
Hypothyroidism
12%
Immune Response
9%
Inflammatory Bowel Disease
43%
Integrated Relaxation Pressure
9%
Iron Deficiency Anemia
18%
Israel
18%
Israeli
19%
Liver
11%
Liver Cirrhosis
18%
Liver Damage
28%
Liver Enzymes
12%
Liver Injury
12%
Maintenance Therapy
12%
P27Kip1
25%
Proton Pump Inhibitors
29%
Receptor Expression
12%
Serum Levels
11%
Thioacetamide
34%
Tumor Necrosis Factor-α
21%
Urea Breath Test
45%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
12%
Adhesive Agent
8%
Adverse Event
6%
Aminotransferase
7%
Arginylglycylaspartic Acid
10%
Carbon 13
8%
Carcinogenesis
7%
Clinical Trial
7%
Colon Carcinoma
14%
Colorectal Carcinoma
12%
Concanavalin A
21%
Concanavalin A-Induced Hepatitis
16%
Crohn's Disease
24%
Cyclin Dependent Kinase Inhibitor
6%
Diabetes Mellitus
9%
Dimethyl Sulfoxide
10%
Dimethylthiourea
9%
Diseases
19%
Etrolizumab
8%
Experimental Liver Injury
8%
Fatty Liver
9%
Fulminant Hepatic Failure
10%
Glucagon Like Peptide 1 Receptor Agonist
8%
Helicobacter Infection
10%
Helicobacter Pylori
66%
Hydroxyl Radical
8%
Hypothyroidism
12%
Infection
11%
Inflammation
10%
Inflammatory Bowel Disease
17%
Integrin Receptor
6%
Liver Cirrhosis
19%
Liver Disease
8%
Liver Enzyme
14%
Liver Injury
55%
Malignant Neoplasm
7%
Neoplasm
9%
Octanoic Acid
8%
Omeprazole
6%
Phosphotransferase
6%
Placebo
11%
Prevalence
10%
Proton Pump Inhibitor
24%
Receptor
10%
Thioacetamide
33%
Triacylglycerol
6%
Tumor Necrosis Factor
25%
Ulcerative Colitis
12%
Urea Breath Test
35%
Urea C 13
33%
Medicine and Dentistry
Achalasia
21%
Adenoma
8%
Biological Therapy
8%
Breathing
17%
Cancer
6%
Coeliac Disease
11%
Colonoscopy
21%
Colorectal Carcinoma
8%
Crohn's Disease
18%
Cyclin Dependent Kinase Inhibitor
6%
Diabetes
8%
Diabetes Mellitus
11%
Diseases
18%
Endoscopy
21%
Esophagogastroduodenoscopy
12%
Esophagus
10%
Ethnic Difference
8%
Etrolizumab
8%
Gastritis
13%
Gastroenterology
6%
Gastroesophageal Reflux
6%
Glucagon Like Peptide 1 Receptor
9%
Glucagon-Like Peptide-1 Agonist
8%
Health Care Cost
7%
Helicobacter Infection
10%
Helicobacter Pylori
79%
Hepatitis C
8%
High Resolution Manometry
21%
Hypochromic Anemia
17%
Infection
15%
Inflammatory Bowel Disease
19%
Iron
9%
Lymphatic Follicle
8%
Maintenance Therapy
8%
Manometry
6%
Membrane Transport Protein
8%
Muscle Contractility
9%
Neoplasm
6%
Nonsteroid Antiinflammatory Agent
6%
Pediatrics
6%
Placebo
6%
Prevalence
24%
Primary Health Care
8%
Proton-Pump Inhibitor
16%
Randomized Controlled Trial
8%
Receptor Expression
12%
Satiety
8%
Ulcerative Colitis
11%
Urea Breath Test
27%
Urea C 13
24%
